TSHA Competitors & Alternatives
Compare Taysha Gene Therapies Inc with similar stocks in the same industry
Biotechnology
TSHA
Main Stock$4.01
Tradestie Score
61
Market Cap
$867.49M
Revenue Growth
1.7%
Analyst Upside
+224.6%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RCUS
Arcus Biosciences, Inc.
|
$19.36
|
$1.43B | - | 48 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$17.06
|
$1.42B | - | 49 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$13.57
|
$1.35B | - | 61 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$26.53
|
$1.32B | - | 54 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$10.86
|
$1.29B | - | 30 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$25.70
|
$1.29B | - | 51 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.20
|
$1.29B | - | 72 | Compare |
|
ZYME
Zymeworks Inc.
|
$28.44
|
$1.28B | - | 35 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.70
|
$1.27B | - | 77 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
More TSHA Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
220 stocks in this industry